Literature DB >> 12874110

Evidence of susceptibility loci on 4q32 and 16p12 for bipolar disorder.

Jenny M Ekholm1, Tuula Kieseppä, Tero Hiekkalinna, Timo Partonen, Tiina Paunio, Markus Perola, Jesper Ekelund, Jouko Lönnqvist, Petra Pekkarinen-Ijäs, Leena Peltonen.   

Abstract

We performed a genome-wide scan for susceptibility loci in bipolar disorder in a study sample colleted from the isolated Finnish population, consisting of 41 families with at least two affected siblings. We identified one distinct locus on 16p12 providing significant evidence for linkage in two-point analysis (Z(max)=3.4). Furthermore, three loci with a two-point LOD score >2.0 were observed with markers on 4q32, 12q23 and Xq25, the latter locus having been earlier identified in one extended Finnish pedigree. In the second stage we fine mapped these chromosomal regions and also genotyped additional family members. In the fine mapping stage, 4q32 provided significant evidence of linkage for the three-point analyses (Z(max)=3.6) and 16p12 produced a three-point LOD score of 2.7. Since the identified chromosomal regions replicate earlier linkage findings in either bipolar disorder or other mental disorders, they should be considered good targets for further genetic analyses.

Entities:  

Mesh:

Year:  2003        PMID: 12874110     DOI: 10.1093/hmg/ddg199

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  18 in total

1.  Genetics of major mood disorders.

Authors:  Wade Berrettini
Journal:  Psychiatry (Edgmont)       Date:  2004-09

2.  Combined analysis from eleven linkage studies of bipolar disorder provides strong evidence of susceptibility loci on chromosomes 6q and 8q.

Authors:  Matthew B McQueen; B Devlin; Stephen V Faraone; Vishwajit L Nimgaonkar; Pamela Sklar; Jordan W Smoller; Rami Abou Jamra; Margot Albus; Silviu-Alin Bacanu; Miron Baron; Thomas B Barrett; Wade Berrettini; Deborah Blacker; William Byerley; Sven Cichon; Willam Coryell; Nick Craddock; Mark J Daly; J Raymond Depaulo; Howard J Edenberg; Tatiana Foroud; Michael Gill; T Conrad Gilliam; Marian Hamshere; Ian Jones; Lisa Jones; Suh-Hang Juo; John R Kelsoe; David Lambert; Christoph Lange; Bernard Lerer; Jianjun Liu; Wolfgang Maier; James D Mackinnon; Melvin G McInnis; Francis J McMahon; Dennis L Murphy; Markus M Nothen; John I Nurnberger; Carlos N Pato; Michele T Pato; James B Potash; Peter Propping; Ann E Pulver; John P Rice; Marcella Rietschel; William Scheftner; Johannes Schumacher; Ricardo Segurado; Kristel Van Steen; Weiting Xie; Peter P Zandi; Nan M Laird
Journal:  Am J Hum Genet       Date:  2005-08-15       Impact factor: 11.025

3.  Genomewide scan and fine-mapping linkage studies in four European samples with bipolar affective disorder suggest a new susceptibility locus on chromosome 1p35-p36 and provides further evidence of loci on chromosome 4q31 and 6q24.

Authors:  Johannes Schumacher; Radka Kaneva; Rami Abou Jamra; Guillermo Orozco Diaz; Stephanie Ohlraun; Vihra Milanova; Young-Ae Lee; Fabio Rivas; Fermin Mayoral; Robert Fuerst; Antonia Flaquer; Christine Windemuth; Eudoxia Gay; Sebastian Sanz; Maria José González; Susana Gil; Francisco Cabaleiro; Francisco del Rio; Fermin Perez; Jesus Haro; Christian Kostov; Vesselin Chorbov; Amelia Nikolova-Hill; Vessela Stoyanova; George Onchev; Ivo Kremensky; Konstantin Strauch; Thomas G Schulze; Peter Nürnberg; Wolfgang Gaebel; Ansgar Klimke; Georg Auburger; Thomas F Wienker; Luba Kalaydjieva; Peter Propping; Sven Cichon; Assen Jablensky; Marcella Rietschel; Markus M Nöthen
Journal:  Am J Hum Genet       Date:  2005-11-02       Impact factor: 11.025

4.  A linkage search for joint panic disorder/bipolar genes.

Authors:  Mark W Logue; Martina Durner; Gary A Heiman; Susan E Hodge; Steven P Hamilton; James A Knowles; Abby J Fyer; Myrna M Weissman
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-12-05       Impact factor: 3.568

5.  Genome-wide searches for bipolar disorder genes.

Authors:  Shaza Alsabban; Margarita Rivera; Peter McGuffin
Journal:  Curr Psychiatry Rep       Date:  2011-12       Impact factor: 5.285

6.  Influence of GRIA1, GRIA2 and GRIA4 polymorphisms on diagnosis and response to treatment in patients with major depressive disorder.

Authors:  Alberto Chiesa; Concetta Crisafulli; Stefano Porcelli; Changsu Han; Ashwin A Patkar; Soo-Jung Lee; Moon Ho Park; Tae-Youn Jun; Alessandro Serretti; Chi-Un Pae
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-11-05       Impact factor: 5.270

7.  Genome-wide parametric linkage analyses of 644 bipolar pedigrees suggest susceptibility loci at chromosomes 16 and 20.

Authors:  Jessica Ross; Wade Berrettini; William Coryell; Elliot S Gershon; Judith A Badner; John R Kelsoe; Melvin G McInnis; Francis J McMahon; Dennis L Murphy; John I Nurnberger; Tatiana Foroud; John P Rice; William B Scheftner; Peter Zandi; Howard Edenberg; William Byerley
Journal:  Psychiatr Genet       Date:  2008-08       Impact factor: 2.458

8.  Association analysis of HSP90B1 with bipolar disorder.

Authors:  Chihiro Kakiuchi; Mizuho Ishiwata; Shinichiro Nanko; Hiroshi Kunugi; Yoshio Minabe; Kazuhiko Nakamura; Norio Mori; Kumiko Fujii; Tadashi Umekage; Mamoru Tochigi; Kazuhisa Kohda; Tsukasa Sasaki; Kazuo Yamada; Takeo Yoshikawa; Tadafumi Kato
Journal:  J Hum Genet       Date:  2007-09-04       Impact factor: 3.172

9.  Genomewide linkage scan for bipolar-disorder susceptibility loci among Ashkenazi Jewish families.

Authors:  M Daniele Fallin; Virginia K Lasseter; Paula S Wolyniec; John A McGrath; Gerald Nestadt; David Valle; Kung-Yee Liang; Ann E Pulver
Journal:  Am J Hum Genet       Date:  2004-06-18       Impact factor: 11.025

10.  A genome-wide linkage study of bipolar disorder and co-morbid migraine: replication of migraine linkage on chromosome 4q24, and suggestion of an overlapping susceptibility region for both disorders on chromosome 20p11.

Authors:  K J Oedegaard; T A Greenwood; A Lunde; O B Fasmer; H S Akiskal; J R Kelsoe
Journal:  J Affect Disord       Date:  2009-10-12       Impact factor: 4.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.